SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on July 20, 2021. The registrant is a Delaware corporation with principal executive offices in Westport, Connecticut. The filing discloses a regulatory event under Item 7.01 (Regulation FD Disclosure) regarding upcoming presentations at the Heart Rhythm 2021 convention.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing focuses solely on the announcement of physician presentations for the PURE EP System.
Guidance, Outlook, and Management Commentary
- Event Announcement: The Company announced it will host two presentations from physician users of its PURE EP System during the annual Heart Rhythm 2021 convention.
- Legal Disclaimer: The Company explicitly states it undertakes no obligation to update, supplement, or amend the materials attached as Exhibit 99.1.
- Regulatory Status: The information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the date and content of the press release attached as Exhibit 99.1 regarding the Heart Rhythm 2021 convention.
- Confirm the trading symbol (BSGM) and exchange (NASDAQ Capital Market) for the Common Stock.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial performance.
- Review the attached press release for specific details on the PURE EP System presentations, as the 8-K body only summarizes the event.